These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Treatment options for DOCK8 deficiency-related severe dermatitis. Ollech A; Mashiah J; Lev A; Simon AJ; Somech R; Adam E; Barzilai A; Hagin D; Greenberger S J Dermatol; 2021 Sep; 48(9):1386-1393. PubMed ID: 34043252 [TBL] [Abstract][Full Text] [Related]
13. The clinical and laboratory spectrum of dedicator of cytokinesis 8 immunodeficiency syndrome in patients with a unique mutation. Broides A; Mandola AB; Levy J; Yerushalmi B; Pinsk V; Eldan M; Shubinsky G; Hadad N; Levy R; Nahum A; Ben-Harosh M; Lev A; Simon A; Somech R Immunol Res; 2017 Jun; 65(3):651-657. PubMed ID: 28070732 [TBL] [Abstract][Full Text] [Related]
14. Genetic, clinical, and laboratory markers for DOCK8 immunodeficiency syndrome. Zhang Q; Davis JC; Dove CG; Su HC Dis Markers; 2010; 29(3-4):131-9. PubMed ID: 21178272 [TBL] [Abstract][Full Text] [Related]
15. Clinical manifestations of hyper IgE syndromes. Freeman AF; Holland SM Dis Markers; 2010; 29(3-4):123-30. PubMed ID: 21178271 [TBL] [Abstract][Full Text] [Related]
16. Successful hematopoietic stem cell transplantation after myeloablative conditioning in three patients with dedicator of cytokinesis 8 deficiency (DOCK8) related Hyper IgE syndrome. Kuşkonmaz B; Ayvaz D; Tezcan İ; Yüce A; Sanal Ö; Çetinkaya DU Bone Marrow Transplant; 2018 Mar; 53(3):339-343. PubMed ID: 29269803 [No Abstract] [Full Text] [Related]
17. Novel mutation in DOCK8-HIES with severe phenotype and successful transplantation. Al Shekaili L; Sheikh F; Al Gazlan S; Al Dhekri H; Al Mousa H; Al Ghonaium A; Al Saud B; Al Mohsen S; Rehan Khaliq AM; Al Sumayli S; Al Zahrani M; Dababo A; AlKawi A; Hawwari A; Arnaout R Clin Immunol; 2017 May; 178():39-44. PubMed ID: 27890707 [TBL] [Abstract][Full Text] [Related]
18. Novel Variants of DOCK8 Deficiency in a Case Series of Iranian Patients. Momtazmanesh S; Rayzan E; Zoghi S; Shahkarami S; Molatefi R; Mohammadzadeh I; Ghaffari J; Mahmoudi H; Dmytrus J; Segarra-Roca A; Somekh I; Witzel M; Hauck F; Boztug K; Klein C; Rezaei N Endocr Metab Immune Disord Drug Targets; 2022; 22(1):159-168. PubMed ID: 33634762 [TBL] [Abstract][Full Text] [Related]
19. Atypical Localization of Eczema Discriminates DOCK8 or STAT3 Deficiencies from Atopic Dermatitis. Kasap N; Kara A; Celik V; Bilgic Eltan S; Akay Haci I; Kose H; Aygun A; Akkelle E; Yakici N; Guner SN; Reisli I; Keles S; Cekic S; Kilic SS; Karaca NE; Gulez N; Genel F; Ozen A; Yucelten AD; Karakoc-Aydiner E; Schmitz-Abe K; Baris S J Clin Immunol; 2023 Nov; 43(8):1882-1890. PubMed ID: 37507632 [TBL] [Abstract][Full Text] [Related]
20. [Hyper-IgE syndromes]. He YY; Liu B; Xiao XP Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jun; 31(11):892-896. PubMed ID: 29775011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]